Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1996
Phase II study of dual 131I-labeled monoclonal antibody therapy with interferon in patients with metastatic colorectal cancerR F Meredith, M B Khazaeli, W E Plott, et al.
Annals of Surgical Oncology|February 6, 2004
Pilot study using a humanized CC49 monoclonal antibody (HuCC49DeltaCH2) to localize recurrent colorectal carcinomaDoreen M Agnese, Shahab F Abdessalam, William E Burak, et al.
Cancer Research|October 1, 1993
A phase I clinical trial of murine monoclonal antibody D612 in patients with metastatic gastrointestinal cancerM N Saleh, M B Khazaeli, W E Grizzle, et al.
Bioconjugate Chemistry|November 18, 2004
Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structureAhmad Safavy, Gunda I Georg, David Vander Velde, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1992
Phase I trial of iodine-131-chimeric B72.3 (human IgG4) in metastatic colorectal cancerR F Meredith, M B Khazaeli, W E Plott, et al.
Human Antibodies and Hybridomas|October 1, 1993
Direct localization comparison of murine and chimeric B72.3 antibodies in patients with colon cancerR F Meredith, M B Khazaeli, W E Grizzle, et al.
Bioconjugate Chemistry|March 20, 2003
Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug deliveryAhmad Safavy, James A Bonner, Harlan W Waksal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Phase I trial of a recombinant vaccinia virus encoding carcinoembryonic antigen in metastatic adenocarcinoma: comparison of intradermal versus subcutaneous administrationR M Conry, M B Khazaeli, M N Saleh, et al.
Pageof 11